Instil Bio Inc.
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -100.0% | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | +8.7% | -4.2% | +0.7% | -10.0% | -17.7% | -32.8% | -97.6% | +0.0% | +0.0% | +0.0% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -76.6% | +265.9% | -59.7% | -80.8% | +95.6% | +388.7% | +25.5% | +35.4% | -61.7% | -80.9% | -59.6% | – | |
| – | -9.0% | +14.3% | -13.8% | +0.0% | -3.1% | -12.2% | -32.4% | -4.3% | +2.8% | -11.7% | -4.1% | – | |
| – | -82.3% | +58.1% | -24.4% | +67.2% | -54.6% | +184.8% | -23.3% | -36.0% | -36.3% | -37.2% | -7.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -1.1% | +0.1% | +0.9% | +0.4% | +29.0% | -57.6% | +44.1% | +0.0% | -50.9% | +100.0% | +1.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -35.3% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.